Patents Assigned to Imagenetix, Inc.
  • Publication number: 20120156286
    Abstract: Disclosed are compositions comprising Coenzyme Q10 and a cetylated fatty acid blend, pharmaceutical formulations comprising the same and methods of increasing the systemic concentration of Coenzyme Q10 in an individual, comprising administering the same to the individual.
    Type: Application
    Filed: July 27, 2011
    Publication date: June 21, 2012
    Applicant: IMAGENETIX, INC.
    Inventor: William P. SPENCER
  • Publication number: 20120029078
    Abstract: The teachings herein are directed to antibacterial and anti-inflammatory pharmaceutical compositions that include myristic acid. Further embodiments herein are directed to methods of administering sufficient amounts of myristic compositions to patients in need thereof in order to prevent or treat inflammation and/or bacterial infection. Myristic acid has been established to outperform other cetylated fatty acids in treating infection and inflammation, such as 1-TDC which includes cetylated myristic acid. The compositions and methods provided herein can further be used with additional anti-inflammatory, antibacterial, and delivery agents.
    Type: Application
    Filed: March 2, 2011
    Publication date: February 2, 2012
    Applicant: IMAGENETIX, INC.
    Inventors: Robert L. Hesslink, JR., William P. Spencer
  • Patent number: 7776914
    Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: August 17, 2010
    Assignee: Imagenetix, Inc.
    Inventors: William P. Spencer, Patrick S. Millsap
  • Patent number: 7612111
    Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: November 3, 2009
    Assignee: Imagenetix, Inc.
    Inventors: William P. Spencer, Patrick S. Millsap
  • Publication number: 20090252692
    Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.
    Type: Application
    Filed: June 16, 2009
    Publication date: October 8, 2009
    Applicant: IMAGENETIX, INC.
    Inventors: William P. SPENCER, Patrick S. MILLSAP
  • Publication number: 20050208162
    Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.
    Type: Application
    Filed: March 22, 2004
    Publication date: September 22, 2005
    Applicant: IMAGENETIX, INC.
    Inventors: William Spencer, Patrick Millsap